Panmure Liberum highlights a take-private offer for Sweden's Viva Wine Group at 8.5 times forecast 2026 EBITDA, exposing how cheaply Naked Wines and Virgin Wines trade. Naked Wines trades at just 3.0 times forward enterprise value to EBITDA, about 80% below the Viva bid multiple, with a buy rating and a 160p target versus a 70p share price. Virgin Wines is valued even lower, with net cash exceeding market value, and is in early growth stages targeting £100 million revenue by 2030. Both stocks are seen as compelling value plays by Panmure Liberum amid ongoing transformations and growth plans.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
